Fate Of COVID-19 Convalescent Plasma Clinical Trials At Stake As US FDA Weighs EUA

Clinical trials would have to move outside US if agency issues emergency use authorization for convalescent plasma, NYU prof says; experts disagree on whether the FDA should issue EUA.